Patents by Inventor Raymond Chang

Raymond Chang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STEM-CyLE: SCIENCE TECHNOLOGY ENGINEERING AND MATHEMATICS CYBERLEARNING ENVIRONMENT
    Publication number: 20190189021
    Abstract: Systems and method are provided for educational content and learning management systems. A system can include a computer-readable storage medium, a graphical user interface, an application programming interface, a communication link for connecting the computer-readable to at least one computing device. The medium can have instructions stored thereon and including learning objects, course materials, educational tutorials, virtual problem-based environments, and gamification elements.
    Type: Application
    Filed: December 19, 2017
    Publication date: June 20, 2019
    Applicant: The Florida International University Board of Trustees
    Inventors: Peter J. Clarke, Raymond Chang Lau, Steve Foo, Debra Davis
  • Methods using Lycium barbarum extracts as neuroprotective agents for retinal ganglion cells degeneration
    Publication number: 20050196478
    Abstract: An Lycium barbarun extract demonstrates a neuroprotective effect on damaged retinal ganglion cells, preventing and preserving retinal ganglion cells from degeneration in the treated subjects after chronic and traumatic neuronal injury or glaucoma. Compositions include an effective amount of an agent and a pharmaceutically acceptable vehicle.
    Type: Application
    Filed: February 25, 2005
    Publication date: September 8, 2005
    Inventors: Kwok-Fai So, Wai-Hung Yuen, Raymond Chang, S. Y. Zee
  • Polysaccharide extract from Lycium barbarum as neuroprotective agent against beta-amyloid peptide neurotoxicity
    Publication number: 20050170028
    Abstract: Extracts of Lycium barbarum serve as a neuroprotective agent against ?-amyloid peptide neurotoxicity which thus permits their use for the treatment of Alzheimer's disease (AD) and for the prevention of neuronal loss in aging against the accumulation of ?-amyloid peptide in the brain. Stress kinases (c-Jun N-terminal kinase and double-stranded RNA-dependent protein kinase) are used as a technological platform for screening neuroprotective drugs.
    Type: Application
    Filed: February 3, 2005
    Publication date: August 4, 2005
    Inventors: Raymond Chang, Wai-Hung Yuen, Kwok-Fai So, S.Y. Zee